Our study showed that synchronous CRC and lung cancer is not very common but has a significant mortality rate. The independent risk factors for CRC or lung cancer have previously been established. Cigarette smoking has been shown as a generally accepted risk factor, especially within lung cancer [11]. Previous studies have also demonstrated that obesity, diabetes, and high dietary meat intake are associated with an increased risk of colon cancer [11]. Multiple risk factors have also been found to contribute to the development of synchronous CRC. African American race, advanced age, high primary tumor grade and size, perineural invasion, elevated CEA, and existing liver metastasis are associated with synchronous CRC and lung tumors [20]. The results of our study showed some differences when it comes to demographic factors that influence CRC and synchronous CRC and lung tumors (Table 1). Previous studies have also indicated a higher incidence of synchronous CRC among men, especially in patients over 70 years [14]. Our study further reinforces this significance, as the data shows a higher percentage of men (74%) than women are diagnosed with synchronous CRC and lung cancer. In our study, the average age of diagnosis for CRC alone or synchronous with lung cancer was around 60 and primarily occurring mostly in white individuals. Interestingly, our data showed that patients with private insurance and those within the low-income quartile were more likely to have synchronous CRC than CRC alone, which was statistically significant. This could be because the patients in low-income quartile might have more comorbidities due to poor health choices and because they might have less access to healthcare.
Regarding location, synchronous CRC with LC arises more commonly in the descending colon and unspecified areas in our group of patients. This differs from metastatic CRC to the lung. Previous studies have shown that rectal and left-sided colon cancer had more predilection for lung metastasis over other sites, such as liver and peritoneum (16). It is important to consider the different venous drainage systems of the colon—the inferior rectum is drained to the systemic circulation via the inferior rectal veins while the rest of the colon drains to the portal system. This may explain why rectal tumors more commonly have metastasis to the lungs [19].
Our study demonstrates that more than half the patients diagnosed with synchronous CRC and lung cancer had advanced-stage disease. This might be because these patients might have a more aggressive disease or have a predilection for cancer. The majority of synchronous CRC and lung cancer patients (75%) undergone supportive care alone. This is quite understandable because these patients had significantly advanced diseases. These patients were also more likely to undergo chemotherapy (54%) than colectomy (15%). Lung lobectomy was performed in 16% of the individuals with synchronous lung and CRC. Overall, synchronous CRC and lung cancer were found to have higher mortality rates than CRC alone. A previous study investigating treatment outcomes in synchronous CRC with lung cancer patients found that subjects who had undergone lung tumor resection had overall better survival than those who did not, with a hazard ratio of 0.482 [17]. We were not able to determine this particular outcome in our study. Another study showed that synchronous CRC patients who had undergone pulmonary metastasectomy had a 65% 5-year survival rate [18]. However, this study looked more are pulmonary metastasis and not primary lung cancer.
Regarding the treatment sequence, our study showed 12% of patients with synchronous CRC and lung cancer underwent treatment of their colorectal cancer first. In comparison, 13% underwent treatment for their lung cancer first. As previously mentioned, most patients underwent supportive care alone. In our study, we could not determine whether any of the patients underwent concurrent management of both lung and colorectal cancer. We assume that this possibly happened. Information on the time interval between colon resections and lobectomies was not available. In one case report study of synchronous CRC and lung cancer in a patient with adenocarcinoma in both locations, confirmed using immunostaining showing primary origins in each location, the patient underwent lobectomy and months later a colon resection was performed [15]. This showed that both surgical procedures could be performed in a sequential manner.
Our study also demonstrates that patients with synchronous CRC and lung cancer have a higher mortality rate than those diagnosed with CRC alone (65% vs 54%). Our results are concurrent with other synchronous cancer studies, which have demonstrated worse outcomes of survival for synchronous CRC compared to CRC alone [14]. Due to lung cancer being the leading cause of cancer-related deaths in the US, this can be considered a contributing factor to the high mortality rate observed within synchronous cancer [2]. One study of 3,102 patients followed over 76 months found that of the 9 patients that succumbed to their illness, all 9 deaths were directly associated to the patients’ lung cancer [11]. Advanced staging (56%) can be another contributor to why higher mortality rates are seen amongst patients with synchronous CRC and lung cancer, as shown in our results. Our analysis shows that patients with synchronous CRC and lung cancer are more likely to present with stage IV than CRC alone.
One of the inherent limitations of this study is that it is a retrospective analysis and there might be missing data. We could not review the histopathology of the CRC or lung cancer to determine synchronous primary lung cancer from metastatic lung cancer. However, we excluded from this study all the lung cancers that were coded with ICD-9 CM code 197.0, which represents metastatic disease to the lungs. Another limitation of this study was the lack of staging of primary lung cancer. The assumption would have been that a higher stage of lung cancer will likely have more contribution to patient mortality. This would have also been important in determining if the high mortality in the synchronous lung and colorectal cancer was due to colorectal cancer or lung cancer. Given the fact that lung cancer is the leading cause of cancer-related deaths in the US, it is reasonable to conclude a higher stage of synchronous lung cancer is more predictive of mortality than colorectal cancer is.